DK1485059T3 - Topisk dapson til behandling af akne - Google Patents

Topisk dapson til behandling af akne

Info

Publication number
DK1485059T3
DK1485059T3 DK02806891T DK02806891T DK1485059T3 DK 1485059 T3 DK1485059 T3 DK 1485059T3 DK 02806891 T DK02806891 T DK 02806891T DK 02806891 T DK02806891 T DK 02806891T DK 1485059 T3 DK1485059 T3 DK 1485059T3
Authority
DK
Denmark
Prior art keywords
acne
dapson
topical
treatment
composition
Prior art date
Application number
DK02806891T
Other languages
English (en)
Inventor
David W Osborne
Original Assignee
Qlt Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qlt Usa Inc filed Critical Qlt Usa Inc
Application granted granted Critical
Publication of DK1485059T3 publication Critical patent/DK1485059T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Floor Finish (AREA)
DK02806891T 2002-02-20 2002-03-18 Topisk dapson til behandling af akne DK1485059T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/081,050 US20030157036A1 (en) 2002-02-20 2002-02-20 Topical dapsone for the treatment of acne
PCT/US2002/008449 WO2003072071A1 (en) 2002-02-20 2002-03-18 Topical dapsone for the treatment of acne

Publications (1)

Publication Number Publication Date
DK1485059T3 true DK1485059T3 (da) 2007-05-07

Family

ID=27733245

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02806891T DK1485059T3 (da) 2002-02-20 2002-03-18 Topisk dapson til behandling af akne

Country Status (23)

Country Link
US (2) US20030157036A1 (da)
EP (1) EP1485059B1 (da)
JP (1) JP2005524651A (da)
KR (1) KR100864129B1 (da)
CN (1) CN1625384A (da)
AT (1) ATE353628T1 (da)
AU (1) AU2002306767B2 (da)
BR (1) BR0215606A (da)
CA (3) CA2855045A1 (da)
DE (1) DE60218227T2 (da)
DK (1) DK1485059T3 (da)
EA (1) EA008022B1 (da)
ES (1) ES2280629T3 (da)
HK (1) HK1072010A1 (da)
IL (1) IL163650A0 (da)
IS (1) IS2454B (da)
MX (1) MXPA02006593A (da)
NO (1) NO20043877L (da)
NZ (1) NZ535363A (da)
PT (1) PT1485059E (da)
SI (1) SI1485059T1 (da)
WO (1) WO2003072071A1 (da)
ZA (1) ZA200407439B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097030A1 (en) * 2002-05-21 2003-11-27 Immune Network Ltd. Use of 4-(4'-aminophenylsulphonyl)-benzoic acid and esters thereof as anti-inflammatory agents
EP1675563A4 (en) * 2003-08-13 2009-07-15 Qlt Usa Inc EMULSION COMPOSITION WITH DAPSON
US20060286108A1 (en) * 2005-06-16 2006-12-21 Bell Katherine A Topical compositions for the treatment of chronic wounds
KR100806051B1 (ko) 2006-09-06 2008-02-26 오교철 답손을 유효성분으로 함유하는 항진균용 약학 조성물
EP2139444A2 (en) * 2007-03-21 2010-01-06 Dow Global Technologies Inc. Sustained-release composition
US20090041686A1 (en) * 2007-08-06 2009-02-12 Osborne David W Topical acne vulgaris composition with a sunscreen
US20110294896A1 (en) * 2007-11-07 2011-12-01 Garret John S Topical Treatment With Dapsone In G6PD-Deficient Patients
BRPI0822264A2 (pt) * 2008-02-27 2014-09-30 Allergan Inc Dapsona para tratar rosácea
RU2012104572A (ru) * 2009-07-30 2013-09-10 Аллерган, Инк. Комбинация дапсона с адапаленом
US20110117182A1 (en) * 2009-07-30 2011-05-19 Allergan, Inc. Combination of dapsone with other anti-acne agents
CN103054792B (zh) * 2011-10-21 2017-06-06 重庆华邦制药有限公司 一种质量稳定的氨苯砜凝胶及其制备方法
KR20130063962A (ko) * 2011-12-07 2013-06-17 가천대학교 산학협력단 디아미노디페닐술폰을 포함하는 골량 저하 질환의 예방 또는 치료용 약학적 조성물
EP2922528B1 (en) * 2012-11-20 2017-05-31 Allergan, Inc. Topical dapsone and dapsone/adapalene compositions and methods for use thereof
CA2956823A1 (en) * 2014-07-31 2016-02-04 Allergan, Inc. Comparative efficacy and tolerability of dapsone 5% in adult versus adolescent females with acne vulgaris
MX2018005083A (es) * 2015-11-04 2019-05-16 Allergan Inc Métodos para el tratamiento de acné comun mediante el uso de composiciones tópicas de dapsona.
CN115887357B (zh) * 2022-11-28 2023-07-11 哈尔滨葵花药业有限公司 氨苯砜凝胶制剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3419009A1 (de) * 1984-05-22 1985-11-28 Dr. Karl Thomae Gmbh, 7950 Biberach Neue substituierte bis(4-aminophenyl)sulfone, ihre herstellung und ihre verwendung als arzneimittel
DE3603577A1 (de) * 1986-02-06 1987-08-13 Joachim K Prof Dr Seydel Neue substituierte 2,4-diamino-5-benzylpyrimidine, deren herstellung und deren verwendung als arzneimittel mit antibakterieller wirksamkeit
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5863560A (en) * 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
US6254866B1 (en) * 1997-10-31 2001-07-03 New Horizons Diagnostics Corporation Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract
US6248324B1 (en) * 1997-10-31 2001-06-19 Vincent Fischetti Bacterial phage associated lysing enzymes for treating dermatological infections
US6277399B1 (en) * 1997-10-31 2001-08-21 New Horizon Diagnostics Corporation Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections
US6200964B1 (en) * 1999-05-28 2001-03-13 Neutrogena Corporation Silicone gel containing salicylic acid
US6056955A (en) * 1999-09-14 2000-05-02 Fischetti; Vincent Topical treatment of streptococcal infections
US20040086469A1 (en) * 2002-10-30 2004-05-06 Osborne David W. Protectant for UV-induced skin damage

Also Published As

Publication number Publication date
CA2776702C (en) 2014-09-02
CA2855045A1 (en) 2003-09-04
SI1485059T1 (sl) 2007-06-30
EP1485059A1 (en) 2004-12-15
AU2002306767B9 (en) 2003-09-09
EA200401084A1 (ru) 2005-08-25
EP1485059A4 (en) 2005-09-21
MXPA02006593A (es) 2004-08-19
CA2477217C (en) 2012-07-17
IS7419A (is) 2004-08-20
EP1485059B1 (en) 2007-02-14
ZA200407439B (en) 2006-06-28
EA008022B1 (ru) 2007-02-27
HK1072010A1 (en) 2005-08-12
ES2280629T3 (es) 2007-09-16
CN1625384A (zh) 2005-06-08
DE60218227T2 (de) 2007-10-31
WO2003072071A1 (en) 2003-09-04
DE60218227D1 (de) 2007-03-29
PT1485059E (pt) 2007-04-30
KR100864129B1 (ko) 2008-10-16
NZ535363A (en) 2007-04-27
ATE353628T1 (de) 2007-03-15
US20030157036A1 (en) 2003-08-21
US20070122435A1 (en) 2007-05-31
CA2776702A1 (en) 2003-09-04
IL163650A0 (en) 2005-12-18
AU2002306767A1 (en) 2003-09-09
BR0215606A (pt) 2004-12-07
IS2454B (is) 2008-11-15
JP2005524651A (ja) 2005-08-18
AU2002306767B2 (en) 2007-09-13
KR20040085214A (ko) 2004-10-07
NO20043877L (no) 2004-09-15
CA2477217A1 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
HK1072010A1 (en) Topical dapsone for the treatment of acne
ATE421877T1 (de) Verwendung von totarol zur behandlung von pruritus
DE60329180D1 (de) Sebum- und schweissabsorbierendes grundierungsset und entsprechendes mehrstufiges verfahren
DE60327804D1 (de) Alanin-2,3-aminomutase
DE60233420D1 (de) Fumagillolderivate und verfahren zu deren herstellung
WO2004043481A3 (en) Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto
WO2004071469A3 (en) Methods of administering a dermatological agent to a subject
BRPI0408228A (pt) inibidores de citocinas
WO2001057022A3 (en) Pyrazole compositions useful as inhibitors of erk
BRPI0408476A (pt) métodos para melhorar a qualidade da pele
ATE555656T1 (de) Verwendung von seh-hemmern als analgetika
TW200510397A (en) Conjugated complement cascade inhibitors
WO2007024574A3 (en) Topical formulations of histone deacetylase inhibitors and methods of using the same
WO2007106622A3 (en) Fungicidal formulation and method of use
DE60004786D1 (de) Verfahren und zusammensetzung zur behandlung von akne
WO2005066116A8 (en) Disubstituted chalcone oximes as selective agonists of rarϝ retinoid receptors
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
BRPI0412424A (pt) composto, composição farmacêutica, método para tratar doenças dermatológicas ou cancerosas em um mamìfero, composição, e, método para tratar doenças relacionadas com a pele ou cancerosas
BRPI0410358A (pt) tratamento tópico de condições da pele
DE60329326D1 (de) Tace inhibitoren
BR0213126A (pt) Compostos heterocìclicos insaturados de 6 membros úteis para inibição seletiva da cascata de coagulação
ATE554757T1 (de) Verwendung von mindestens einem 2-alkyl-furan als wirkstoff zur depigmentierung oder aufhellung
EA200200948A1 (ru) Лечение псориаза
MX2008012905A (es) Compuestos de naftalendiona.
AP1777A (en) Use of topical compositions for the control of microbial diseases of the nail.